Insmed | Passività Correnti



Current Liabilities Cambiamento Data
BioMarin Pharmaceutical USD 628.21M 21.22M 2025-03
Cytokinetics USD 159.73M 19.95M 2025-03
DBV Technologies USD 30.91M 3.53M 2024-09
Dynavax Technologies USD 68.38M 10.26M 2025-03
Gilead Sciences USD 12B 279M 2024-12
Insmed USD 239.23M 58.29M 2025-03
Novartis USD 28.69B 560M 2024-12
Regeneron Pharmaceuticals USD 3.57B 2.13B 2025-03
Sarepta Therapeutics USD 605.59M 126.1M 2025-03
Ultragenyx Pharmaceutical USD 344.15M 59.14M 2024-12
Vertex Pharmaceuticals USD 3.56B 408.5M 2024-12



Insmed Passività Correnti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.